A Phase 2 Safety and Efficacy Study of Neoadjuvant/adjuvant Darovasertib for Localized Ocular Melanoma.
Anthony M. Joshua,Roderick O'day,William Glasson,David Sia,Lindsay McGrath, Malaka Ameratunga,Rasha Cosman,Svetlana Cherepanoff, Michael O'Quigley, Darrin M. Beaupre,Max Conway, Li-Anne Lim,John McKenzie,Daniel McKay,Mark J. Shackleton,Adrian Fung,Timothy Isaacs, Jacob Yousif, Christine Brooks, Trifon Psaroulis Journal of Clinical Oncology（2024）
AI 理解论文
溯源树
样例
